{"filing":{"accession_number":"0001434647-26-000041","cik":"0001434647","ticker":"ZVRA","company_name":"ZEVRA THERAPEUTICS, INC.","form":"8-K","filing_date":"2026-06-05","report_date":null,"primary_document":"zvra-20260604.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1434647/000143464726000041/zvra-20260604.htm"},"events":[{"id":6571,"run_id":5750,"accession_number":"0001434647-26-000041","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes on three proposals: election of two Class II directors (Douglas W. Calder and Corey Watton), ratification of Ernst \u0026 Young LLP as independent auditor, and a charter amendment to declassify the board. The filing provides detailed vote tabulations showing that Proposals 1 and 2 passed while Proposal 3 failed to achieve the required 66 2/3% threshold. This is a material disclosure of shareholder voting results as required by Item 5.07.","company_name":"ZEVRA THERAPEUTICS, INC.","ticker":"ZVRA","filing_date":"2026-06-05","form":"8-K","submitted_at":null,"items":[{"id":4831,"accession_number":"0001434647-26-000041","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes on three proposals: election of two Class II directors (Douglas W. Calder and Corey Watton), ratification of Ernst \u0026 Young LLP as independent auditor, and a charter amendment to declassify the board. The filing provides detailed vote tabulations showing that Proposals 1 and 2 passed while Proposal 3 failed to achieve the required 66 2/3% threshold. This is a material disclosure of shareholder voting results as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:21:06.445895+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4831,"accession_number":"0001434647-26-000041","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 discloses the results of the 2026 Annual Meeting of Stockholders held on June 4, 2026, including voting outcomes on three proposals: election of two Class II directors (Douglas W. Calder and Corey Watton), ratification of Ernst \u0026 Young LLP as independent auditor, and a charter amendment to declassify the board. The filing provides detailed vote tabulations showing that Proposals 1 and 2 passed while Proposal 3 failed to achieve the required 66 2/3% threshold. This is a material disclosure of shareholder voting results as required by Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T20:21:06.445895+00:00","company_name":"ZEVRA THERAPEUTICS, INC.","ticker":"ZVRA","filing_date":"2026-06-05"}]}